The lncRNA DUXAP8, transcribed from a pseudogene, modulates both the P3K/AKT/mTOR pathway and the EZH2-E-cadherin/RHOB pathways to exert its role in inducing breast cancer radioresistance (77). Here, DUXAP8 is linked to breast carcinoma.